BioScale (Cambridge, MA) a commercial-stage therapeutic and diagnostics protein biomarker analytics device company, closed a $25M Series D financing. Participants include Morningside Venture, New Science Ventures, WFD Ventures and F2 Ventures.
Gyros (Sweden) a commercial-stage provider of platform-based tools for therapeutic protein assay optimization, closed a $10.4M Series C* financing. Participants include SLS Invest and Industrifonden.
*Investment round undisclosed